Scientists guilty of 'hyping' benefits of gene research
By The Independent,
The Independent (UK)
| 09. 05. 2005
The leading fertility scientist Lord Winston has hit out at senior scientists, including two Nobel laureates, for making exaggerated claims about the supposed benefits of scientific research, warning they could trigger a public backlash.
Speaking on the eve of his presidential address to the annual meeting of the British Association for the Advancement of Science at Trinity College, Dublin, the former head of fertility medicine at the Hammersmith Hospital in London also criticised the "hype" over stem cells. He said stem cells are unlikely to be of much use for many years.
Lord Winston called on his colleagues to use more moderate language when describing scientific breakthroughs, singling out in his speech senior scientists and naming two Nobel laureates for making dangerously arrogant remarks.
"James Watson's assertion about the value of tampering with the human germ-line are a pretty good example," he said. Professor Watson, who won a Nobel prize for discovering the DNA double helix with Francis Crick, has extolled the possibility of altering the genes of germ-line sperm or egg cells to eradicate inherited diseases.
Lord Winston also...
Related Articles
By Fyodor D. Urnov and Sadik H. Kassim, Nature | 04.21.2026
In February, the US Food and Drug Administration (FDA) proposed a radical rethink of how scientists, physicians and manufacturers develop personalized genetic therapies. The regulator’s suggested introduction of a ‘plausible mechanism pathway’ should increase incentives for drug companies to develop...
By Miguel Muñoz, Cadena SER | 08.04.2026
"Para ellos, una familia numerosa no solo es una preferencia personal, sino que es una obligación. Creen que tener tantos hijos como sea posible es necesario para evitar un futuro apocalíptico", aseguraba Xavier Orri, periodista y cofundador de Página Internacional...
By Ryan Knutson and Jessica Mendoza, The Journal. | 03.27.2026
Genetically engineered babies are banned in the U.S. But that isn’t stopping Silicon Valley tech titans from trying to make one. In this final installment from The Journal’s investigation into the fringes of the fertility industry, WSJ’s Emily Glazer reports...
By Antonio Regalado, MIT Technology Review | 03.30.2026
After operating in secrecy for years, a startup company called R3 Bio, in Richmond, California, suddenly shared details about its work last week—saying it had raised money to create nonsentient monkey “organ sacks” as an alternative to animal testing.
In...